Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Inspire Medical Up 15% After Breakout, Analysts Say It's A Buy
Inspire Medical Up 15% After Breakout, Analysts Say It's A Buy

Inspire Medical Systems (NYSE: INSP) is up nearly 15% since breaking out of cup-with-handle base on May 3. The base’s buy point was above $277.18, which you can see on the Inspire Medical Systems

Eilt: Erstklassige Studienergebnisse im Kampf gegen Hautkrebs. Neuer 217% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 217% mit Biotech Aktientip Vidac
Eilt: Erstklassige Studienergebnisse im Kampf gegen Hautkrebs. Neuer 217% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 217% mit Biotech Aktientip Vidac

Eilt: Erstklassige Studienergebnisse im Kampf gegen Hautkrebs. Neuer 217% Biotech Hot Stock nach 134.452% mit Biogen

 

05.07.23 08:17

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Eilt: Sensationelle Studienergebnisse - Massives Kaufsignal. Neuer 224% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Sensationelle Studienergebnisse - Massives Kaufsignal. Neuer 224% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Sensationelle Studienergebnisse - Massives Kaufsignal. Neuer 224% Biotech Aktientip nach 31.205% mit Amgen ($AMGN)

 

04.07.23

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Freyr Battery Powers Up After Successful Tests, NYSE Presentation
Freyr Battery Powers Up After Successful Tests, NYSE Presentation

Investors dream of getting into a promising stock early before it goes on a rocket ride. In hindsight, plenty of investors are kicking themselves for not seeing the potential of Apple Inc.

Down Over 80%, is Pet Insurer Trupanion Worth the Risk Premium?
Down Over 80%, is Pet Insurer Trupanion Worth the Risk Premium?

As shareholders of pet insurer Trupanion Inc. (NASDAQ: TRUP) learned last month, when you post a net loss that's twice what Wall Street expected, things get a little fuzzy.

The May 5

MoonLake Immunotherapeutics Makes a Moonshot on Trials
MoonLake Immunotherapeutics Makes a Moonshot on Trials

Clinical stage biotech MoonLake Immunotherapeutics AG (NASDAQ: MLTX) shares spiked 70% on positive phase two clinical trial results. The company specializes in nanobodies, fragments of antibodies

Drugmaker GSK: Becoming a Healthier Value Stock
Drugmaker GSK: Becoming a Healthier Value Stock

Like most stocks during the dot-com bubble, GSK PLC (NYSE: GSK) partied like it was 1999. In the two decades since, missteps and competitive pressures slashed roughly 50% from the U.K. pharmaceuti

PetVivo Sales Spryng Higher on Injectable OA Relief for Pets
PetVivo Sales Spryng Higher on Injectable OA Relief for Pets

Developmental biomedical device company PetVivo Holdings Inc. (OTCMKTS: PETV) makes pet medical devices and therapeutics. What kind of medical devices would pets need? Pacemakers? Artificial hearts

Sarepta Therapeutics Gets FDA Nod, Drops Warning (or Opportunity?)
Sarepta Therapeutics Gets FDA Nod, Drops Warning (or Opportunity?)

On May 15, Sarepta Therapeutics Inc. (NASDAQ: SRPT) learned that its treatment for Duchenne muscular dystrophy (DMD) was recommended for approval by the Food and Drug Administration (FDA)

ImmunoGen Stock Continues to Defy Gravity on Phase 2 Trials
ImmunoGen Stock Continues to Defy Gravity on Phase 2 Trials

ImmunoGen Inc. (NASDAQ: IMGN) is a commercial-stage biotechnology company leading in antibody-drug conjugates (ADC). ADCs are like heat-seeking missiles that target and selectively deliver

Patterson Companies Leverages Healthcare For Income Investors
Patterson Companies Leverages Healthcare For Income Investors

Patterson Companies, Inc. (NASDAQ: PDCO) is a dual-story that includes healthcare for humans and animals. The company operates in 2 segments, Dental and Animal Health, and both are growing. The

T-Mobile Stock's Decline: Does Value Potential Exist?
T-Mobile Stock's Decline: Does Value Potential Exist?

Investors rarely get to consider a blue-chip company like T-Mobile US (NASDAQ: TMUS) amid a decline of more than 17% during the past two months. As the underlying stock carries a beta of only

Agilent Technologies Stock: Ready to Rise off the Floor
Agilent Technologies Stock: Ready to Rise off the Floor

Agilent Technologies Inc. (NYSE: A) stock is underperforming the market, trading down 19% year-to-date. Agilent is a leading global provider of laboratory technologies and equipment.

It counts

DexCom Clears Base, Wall Street Eyes Double-Digit Earnings Growth
DexCom Clears Base, Wall Street Eyes Double-Digit Earnings Growth

You generally associate Super Bowl commercials with products made by PepsiCo Inc. (NYSE: PEP) or the Coca-Cola Co. (NYSE: KO), but earlier this year, glucose-monitoring geat maker DexCom Inc.

Medical Stocks Waters, Agilent, Illumina Show Growth Potential
Medical Stocks Waters, Agilent, Illumina Show Growth Potential

Investors seeking growth often have no choice other than paying up for a stock with strong potential. However, there are some stocks that appear to be trading at low valuations relative to their

Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand
Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand

After a pandemic pause, hip and knee replacements are back. Long-postponed surgeries are being rescheduled, which is bad for business at insurance companies like UnitedHealth Group Inc. (NYSE:

Is NexTier-Patterson UTI Deal A Sign Of More Consolidation Ahead?
Is NexTier-Patterson UTI Deal A Sign Of More Consolidation Ahead?

Shares of Patterson UTI Energy Inc. (NASDAQ: PTEN) and NexTier Oilfield Solutions (NYSE: NEX) were both trading higher on June 15 following news that the companies agreed to combine in a merger of

Bullish or Bearish? Vetting Animal Health Care Stocks
Bullish or Bearish? Vetting Animal Health Care Stocks

Dogs and cats were among the biggest beneficiaries of the pandemic thanks to more attention from housebound pet owners. Pet adoption trends also skyrocketed. 

As Fido and Fluffy were spoiled more

Clarence Seedorf and Khabib Nurmagomedov, With Their SK Sports Holding, Sign Global Partnership With FITLIGHT
Clarence Seedorf and Khabib Nurmagomedov, With Their SK Sports Holding, Sign Global Partnership With FITLIGHT

FITLIGHT becomes the official technology partner of SK Sports Holding

 

MIAMI, FL / ACCESSWIRE / June 15, 2023 / SK Sports Holding, which opened its first Seedorf Khabib Performance Club in

Clarence Seedorf und Khabib Nurmagomedov unterzeichnen mit ihrer SK Sports Holding eine weltweite Partnerschaftsvereinbarung mit FITLIGHT
Clarence Seedorf und Khabib Nurmagomedov unterzeichnen mit ihrer SK Sports Holding eine weltweite Partnerschaftsvereinbarung mit FITLIGHT

 

FITLIGHT wird offizieller Technologiepartner von SK Sports Holding

 

MIAMI, FL / ACCESSWIRE / 15. Juni 2023 / SK Sports Holding, die im Jahr 2022 ihren ersten Seedorf Khabib Performance

Humana's Fall Creates A Rare dip Buying Opportunity
Humana's Fall Creates A Rare dip Buying Opportunity

Investors are facing one of the rarest cases in financial markets, where a deeply entrenched enterprise operating in one of the most 'defensive' sectors has left a pain trail following a 15.3%

DarioHealth is an AI-Powered Digital Therapeutics Play
DarioHealth is an AI-Powered Digital Therapeutics Play

DarioHealth Co. (NASDAQ: DRIO) is an AI-powered digital therapeutics platform and provider that adaptively personalizes monitoring and treatments for chronic diseases. The mobile app manages five

Novartis Stock Screams Value After Chinook Therapeutics Buyout
Novartis Stock Screams Value After Chinook Therapeutics Buyout

Don’t be fooled by the fact that Novartis AG (NYSE:NVS) is trading near an all-time high. The Swiss pharmaceutical giant is still a good value.

That value proposition took a huge step forward on